APIXABAN FOR THE REDUCTION OF THROMBO-EMBOLISM IN PATIENTS WITH DEVICE-DETECTED SUB-CLINICAL ATRIAL FIBRILLATION

Upcoming Events

Twitter

[fts_twitter twitter_name=Artesia_RCT tweets_count=3 cover_photo=no stats_bar=no show_retweets=no show_replies=no twitter_height=200]

LinkedIn